102 related articles for article (PubMed ID: 30987746)
21. Antidepressants for depression in people with physical illness.
Gill D; Hatcher S
Cochrane Database Syst Rev; 2000; (2):CD001312. PubMed ID: 10796770
[TBL] [Abstract][Full Text] [Related]
22. Smartphone Cognitive Behavioral Therapy as an Adjunct to Pharmacotherapy for Refractory Depression: Randomized Controlled Trial.
Mantani A; Kato T; Furukawa TA; Horikoshi M; Imai H; Hiroe T; Chino B; Funayama T; Yonemoto N; Zhou Q; Kawanishi N
J Med Internet Res; 2017 Nov; 19(11):e373. PubMed ID: 29101095
[TBL] [Abstract][Full Text] [Related]
23. [Refractory depression].
Matsushima E
Nihon Rinsho; 1994 May; 52(5):1262-7. PubMed ID: 8007398
[TBL] [Abstract][Full Text] [Related]
24. [Management of treatment-resistant depression (author's transl)].
Kielholz P; Terzani S; Gastpar M
Dtsch Med Wochenschr; 1978 Feb; 103(6):241-3. PubMed ID: 627181
[TBL] [Abstract][Full Text] [Related]
25. Plasticity-augmented psychotherapy for refractory depressive and anxiety disorders.
Choi KY; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():134-47. PubMed ID: 27072378
[TBL] [Abstract][Full Text] [Related]
26. Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation (rTMS) are resistant to the effects of rapid tryptophan depletion.
O'Reardon JP; Cristancho P; Pilania P; Bapatla KB; Chuai S; Peshek AD
Depress Anxiety; 2007; 24(8):537-44. PubMed ID: 17131353
[TBL] [Abstract][Full Text] [Related]
27. Treatment of resistant depression. Review on the efficacy of various biological treatments, specifically in major depression resistant to cyclic antidepressants.
Nolen WA; Haffmans J
Int Clin Psychopharmacol; 1989 Jul; 4(3):217-28. PubMed ID: 2571635
[TBL] [Abstract][Full Text] [Related]
28. Antidepressant monotherapy and combination of antidepressants in the treatment of resistant depression in current clinical practice: A retrospective study.
Bares M; Novak T; Kopecek M; Stopkova P; Höschl C
Int J Psychiatry Clin Pract; 2010 Nov; 14(4):303-8. PubMed ID: 24917443
[TBL] [Abstract][Full Text] [Related]
29. Post-amphetamine depression of self-stimulation responding from the substantia nigra: reversal by tricyclic antidepressants.
Kokkinidis L; Zacharko RM; Predy PA
Pharmacol Biochem Behav; 1980 Sep; 13(3):379-83. PubMed ID: 7422693
[TBL] [Abstract][Full Text] [Related]
30. Do depressed patients on adjunctive atypical antipsychotics demonstrate a better quality of life compared to those on antidepressants only? A comparative cross-sectional study of a nationally representative sample of the US population.
Al-Ruthia YS; Hong SH; Solomon D
Res Social Adm Pharm; 2015; 11(2):228-40. PubMed ID: 25023755
[TBL] [Abstract][Full Text] [Related]
31. Lithium augmentation therapy in refractory depression-update 2002.
Bauer M; Forsthoff A; Baethge C; Adli M; Berghöfer A; Döpfmer S; Bschor T
Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):132-9. PubMed ID: 12904977
[TBL] [Abstract][Full Text] [Related]
32. Effects of chronic bryostatin-1 on treatment-resistant depression in rats.
Alkon DL; Hongpaisan J; Sun MK
Eur J Pharmacol; 2017 Jul; 807():71-74. PubMed ID: 28472666
[TBL] [Abstract][Full Text] [Related]
33. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis.
Sidor MM; Macqueen GM
J Clin Psychiatry; 2011 Feb; 72(2):156-67. PubMed ID: 21034686
[TBL] [Abstract][Full Text] [Related]
34. The impact of treatment-resistant depression on health care utilization and costs.
Crown WH; Finkelstein S; Berndt ER; Ling D; Poret AW; Rush AJ; Russell JM
J Clin Psychiatry; 2002 Nov; 63(11):963-71. PubMed ID: 12444808
[TBL] [Abstract][Full Text] [Related]
35. What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials.
Berlim MT; Turecki G
Eur Neuropsychopharmacol; 2007 Nov; 17(11):696-707. PubMed ID: 17521891
[TBL] [Abstract][Full Text] [Related]
36. Walking on thin ice: the use of triple antidepressant combinations in refractory melancholic depression.
Restifo S
Australas Psychiatry; 2012 Apr; 20(2):134-7. PubMed ID: 22467559
[TBL] [Abstract][Full Text] [Related]
37. We all know what we mean by treatment-resistant depression - don't we?
Anderson IM
Br J Psychiatry; 2018 May; 212(5):259-261. PubMed ID: 29693539
[TBL] [Abstract][Full Text] [Related]
38. Antidepressants in the treatment of psychosis with comorbid depression in Parkinson disease.
Voon V; Lang AE
Clin Neuropharmacol; 2004; 27(2):90-2. PubMed ID: 15252271
[TBL] [Abstract][Full Text] [Related]
39. Attention-deficit hyperactivity disorder comorbidity and antidepressant resistance among patients with major depression: A nationwide longitudinal study.
Chen MH; Pan TL; Hsu JW; Huang KL; Su TP; Li CT; Lin WC; Tsai SJ; Chang WH; Chen TJ; Bai YM
Eur Neuropsychopharmacol; 2016 Nov; 26(11):1760-1767. PubMed ID: 27667705
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
